Fidelity Investments’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$596M Buy
4,334,761
+13,929
+0.3% +$1.91M 0.03% 421
2025
Q1
$779M Buy
4,320,832
+6,818
+0.2% +$1.23M 0.05% 311
2024
Q4
$676M Buy
4,314,014
+21,133
+0.5% +$3.31M 0.04% 361
2024
Q3
$781M Buy
4,292,881
+9,115
+0.2% +$1.66M 0.05% 336
2024
Q2
$787M Buy
4,283,766
+39,874
+0.9% +$7.32M 0.05% 305
2024
Q1
$755M Buy
4,243,892
+1,857,994
+78% +$331M 0.05% 335
2023
Q4
$296M Sell
2,385,898
-243,485
-9% -$30.2M 0.02% 596
2023
Q3
$305M Sell
2,629,383
-52,214
-2% -$6.06M 0.03% 551
2023
Q2
$315M Buy
2,681,597
+484,639
+22% +$56.9M 0.03% 561
2023
Q1
$176M Buy
2,196,958
+88,105
+4% +$7.05M 0.02% 760
2022
Q4
$167M Buy
2,108,853
+2,419
+0.1% +$192K 0.02% 759
2022
Q3
$147M Buy
2,106,434
+178
+0% +$12.4K 0.02% 800
2022
Q2
$138M Sell
2,106,256
-236
-0% -$15.5K 0.01% 833
2022
Q1
$140M Buy
2,106,492
+128,203
+6% +$8.53M 0.01% 933
2021
Q4
$138M Buy
1,978,289
+75,884
+4% +$5.31M 0.01% 947
2021
Q3
$99.3M Buy
1,902,405
+134,488
+8% +$7.02M 0.01% 1111
2021
Q2
$120M Buy
1,767,917
+426,020
+32% +$29M 0.01% 1042
2021
Q1
$103M Buy
1,341,897
+89,511
+7% +$6.9M 0.01% 1051
2020
Q4
$75.1M Sell
1,252,386
-76,900
-6% -$4.61M 0.01% 1154
2020
Q3
$57.2M Hold
1,329,286
0.01% 1142
2020
Q2
$55.1M Buy
1,329,286
+181,000
+16% +$7.5M 0.01% 1120
2020
Q1
$49.7M Hold
1,148,286
0.01% 1031
2019
Q4
$63.6M Hold
1,148,286
0.01% 1107
2019
Q3
$39.9M Hold
1,148,286
﹤0.01% 1275
2019
Q2
$46.2M Sell
1,148,286
-87,114
-7% -$3.51M 0.01% 1260
2019
Q1
$40.6M Hold
1,235,400
﹤0.01% 1299
2018
Q4
$25.7M Buy
1,235,400
+300,000
+32% +$6.23M ﹤0.01% 1457
2018
Q3
$16.4M Sell
935,400
-264,600
-22% -$4.65M ﹤0.01% 1763
2018
Q2
$17.8M Hold
1,200,000
﹤0.01% 1759
2018
Q1
$12.1M Hold
1,200,000
﹤0.01% 1904
2017
Q4
$12.6M Hold
1,200,000
﹤0.01% 1880
2017
Q3
$12M Buy
+1,200,000
New +$12M ﹤0.01% 1883